Pricing Log in Create free account
Saturday 17 October 2026 Export DHR’s income statement to Excel — free account

Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.

228.97 2.53 −1.09%
Market cap
$162.7B
P/E
40.5×
Fwd P/E
29.2×
Dividend yield
0.66%
F-score
6/9
Altman Z
4.52
Beneish M
−2.57
Dividend safety
69/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Danaher Corporation (DHR) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Danaher Corporation (DHR) trades at a price to free cash flow of 29.4×. Over the past ten years it has ranged from 11.4× (September 2015) to 40.7× (August 2024); the current reading is higher than 80% of that period. That is below the Diagnostics & Research industry median of 35.8× and above the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 30.8× (2.48%)
FY2024 31.6× 5.88%
FY2023 29.9× 31.20%
FY2022 22.8× (22.16%)
FY2021 29.2× 13.89%
FY2020 25.7× (12.18%)
FY2019 29.2× 57.14%
FY2018 18.6× (4.13%)
FY2017 19.4× 18.22%
FY2016 16.4× 26.10%

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 24.5× (3.02%)
Mar 2026 25.2× (18.12%)
Dec 2025 30.8× 9.99%
Sep 2025 28.0× (3.30%)
42 more quarters

Against its own ten years

Low 11.4× High 40.7×
Ten-year median 24.1×
Current reading's percentile 80

Price to free cash flow against peers

Company Price to free cash flow
IQV IQVIA Holdings Inc. compare 19.6×
DHR Danaher Corporation 29.4×
TMO Thermo Fisher Scientific Inc. compare 34.8×
IDXX IDEXX Laboratories, Inc. compare 35.8×
MTD Mettler-Toledo International, Inc. compare 37.8×
A Agilent Technologies, Inc. compare 38.4×
ILMN Illumina, Inc. compare 43.2×
WAT Waters Corporation compare 117×
NTRA Natera, Inc. compare 667×
Diagnostics & Research industry median 35.8×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on DHR